Marico Q1 FY26 revenue rose 23.3% as India business and digital brands powered growth (resurfacing an August 2025 report)
Marico reported Q1 FY26 consolidated revenue of Rs 3,259 crore, up 23.3% year on year, while net profit grew 8.2% to Rs 513 crore, according to results disclosed in early August 2025. India revenue rose 27.2%, supported by core portfolios, foods and digital-first brands. The company also increased its stake in Plix maker Satiya Nutraceuticals to 60%.
What happened
Marico posted Q1 FY26 revenue growth of 23.31% and net-profit growth of 8.2%, led by strong India performance, core portfolios, foods and digital-first brands.
Key facts
- Q1 FY26 consolidated net profit: Rs 513 crore, up 8.2% YoY
- Revenue from operations: Rs 3,259 crore, up 23.31% YoY
- India revenue: Rs 2,495 crore, up 27.17% YoY
- International revenue: Rs 764 crore, up 12.91% YoY
- India PBT: Rs 469 crore
- International PBT: Rs 213 crore
- Stake in Satiya Nutraceuticals increased to 60% on a fully diluted basis
Why this matters
Raising its stake in Plix maker Satiya Nutraceuticals to 60% deepens Marico’s exposure to high-growth wellness and digital-first consumer categories.
What to watch
- India volume growth versus value growth in Parachute, Saffola and value-added hair oils.
- Sequential operating-margin movement, since profit growth of 8.2% materially lagged revenue growth of 23.3%.
- Copra, edible-oil and packaging-price trends and any resulting price hikes or grammage changes.
- Plix revenue growth, distribution expansion, profitability and the pace of post-acquisition integration.
- Foods and digital-first brands' share of India revenue and advertising-to-sales intensity.
- Quick-commerce availability, repeat purchase metrics and competitive launches in nutrition, wellness and foods.
- International business growth and currency effects, especially in Bangladesh, MENA and South Africa markets.
- Accelerate distribution expansion for Plix and other digital-first brands across general trade, modern trade and quick commerce.
- Increase cross-selling of health, nutrition and foods products through Marico's India sales network following the stake increase in Satiya Nutraceuticals.
- Sustain brand investment in premium and value-added portfolios while using pack-price architecture to protect mass-market volumes.
- Pursue further minority-stake increases, partnerships or acquisitions in health, wellness, foods and digital-native categories.
- Manage copra, edible-oil, packaging and freight exposure through calibrated pricing, procurement and cost-control actions.